Cargando…
lncRNA MCF2L-AS1/miR-105/ IL-1β Axis Regulates Colorectal Cancer Cell Oxaliplatin Resistance
BACKGROUND: Interactions between non-coding RNAs and mRNAs have been shown to play key roles in colorectal cancer (CRC) resistance to chemotherapeutic drugs, but the regulatory network of these ncRNA/mRNA interactions in the context of CRC cell resistance to oxaliplatin has yet to be fully defined....
Autores principales: | Cai, Mao, Hu, Wanle, Huang, Chongjie, Zhou, Chongjun, Li, Jiante, Chen, Yanyu, Yu, Yaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610381/ https://www.ncbi.nlm.nih.gov/pubmed/34824551 http://dx.doi.org/10.2147/CMAR.S313905 |
Ejemplares similares
-
LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p/RAB22A axis
por: Kong, Wencheng, et al.
Publicado: (2021) -
The lncRNA MCF2L-AS1 controls osteogenic differentiation by regulating miR-33a
por: Chen, Qiaofeng, et al.
Publicado: (2020) -
LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis
por: Xia, Xiaoyan, et al.
Publicado: (2022) -
Quercetin Arrests in G2 phase, Upregulates INXS LncRNA and Downregulates UCA1 LncRNA in MCF-7 Cells
por: Rezaie, Fatemeh, et al.
Publicado: (2021) -
LncRNA ROR/miR-145-5p axis modulates the osteoblasts proliferation and apoptosis in osteoporosis
por: Fu, Yin, et al.
Publicado: (2021)